Can Novavax Stock Overcome Growing Vaccine Distrust?
October 23, 2020 at 14:23 PM EDT
InvestorPlace - Stock Market News, Stock Advice & Trading Tips NVAX stock may be riding high on AstraZeneca's clinical trial blunder, but the path forward is not smooth for Novavax. Here's why. The post Can Novavax Stock Overcome Growing Vaccine Distrust? appeared first on InvestorPlace . More From InvestorPlace Why Everyone Is Investing in 5G All WRONG Top Stock Picker Reveals His Next 1,000% Winner Radical New Battery Could Dismantle Oil Markets Revolutionary Tech Behind 5G Rollout Is Being Pioneered By This 1 Company